3.3(top 10%)
impact factor
2.8K(top 10%)
papers
93.9K(top 5%)
citations
119(top 5%)
h-index
3.4(top 10%)
impact factor
3.5K
all documents
96.7K
doc citations
175(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Primary systemic amyloidosis: clinical and laboratory features in 474 casesSeminars in Hematology1995882
2Rituximab: Mechanism of ActionSeminars in Hematology2010629
3Epidemiology and Risk Factors for Venous ThrombosisSeminars in Hematology2007572
4Chronic graft-versus-host disease and other late complications of bone marrow transplantationSeminars in Hematology1991556
5Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue CoalitionSeminars in Hematology1997547
6The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigueSeminars in Hematology1997474
7A Dirty Dozen: Twelve P-Value MisconceptionsSeminars in Hematology2008459
8Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytesSeminars in Hematology1975430
9Therapeutic goals in the treatment of Gaucher diseaseSeminars in Hematology2004418
10Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocolsSeminars in Hematology1986381
11Diagnosis and classification of the polycythemiasSeminars in Hematology1975364
12Pathophysiology of Graft-Versus-Host DiseaseSeminars in Hematology2006358
13Function and regulation of transferrin and ferritinSeminars in Hematology1998342
14Essential thrombocythemia: an interim report from the Polycythemia Vera Study GroupSeminars in Hematology1986329
15Multiple myeloma: clinical evaluation of plasma cell lymphoproliferative disorders and initial managementSeminars in Hematology1997303
16Epidemiology of Anemia in Older AdultsSeminars in Hematology2008300
17Iron Sequestration and Anemia of InflammationSeminars in Hematology2009283
18Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignanciesSeminars in Hematology1997279
19Red blood cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipidsSeminars in Hematology1993265
20A 50-Year Journey to Cure Childhood Acute Lymphoblastic LeukemiaSeminars in Hematology2013264
21Mantle-cell lymphomaSeminars in Hematology1999262
22Anemia in Clinical Practice—Definition and Classification: Does Hemoglobin Change With Aging?Seminars in Hematology2015257
23Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspectsSeminars in Hematology1967255
24The anemia of chronic disordersSeminars in Hematology1966251
25Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic diseaseSeminars in Hematology2001246
26Fundamentals of the psoralen-based Helinx[trade ] technology for inactivation of infectious pathogens and leukocytes in platelets and plasmaSeminars in Hematology2001246
27Blood group ABH and Ii antigens of human erythrocytes: chemistry, polymorphism, and their developmental changeSeminars in Hematology1981246
28Lenalidomide and Thalidomide: Mechanisms of Action—Similarities and DifferencesSeminars in Hematology2005235
29Rituximab-Associated InfectionsSeminars in Hematology2010230
30Antithrombin: structure and functionSeminars in Hematology1991228
31Hereditary spherocytosis—defects in proteins that connect the membrane skeleton to the lipid bilayerSeminars in Hematology2004225
32Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy-the European group for blood and marrow transplantation experienceSeminars in Hematology2000223
33Clinical features of large granular lymphocyte leukemiaSeminars in Hematology2003220
34The role of chromosome translocations in leukemogenesisSeminars in Hematology1999218
35Diagnosis of factor VIII versus nonspecific inhibitorsSeminars in Hematology1993216
36Gaucher disease type 1: Revised recommendations on evaluations and monitoring for adult patientsSeminars in Hematology2004215
37The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatmentSeminars in Hematology1988208
38Flow cytometry in analysis of cell cycle and apoptosisSeminars in Hematology2001207
39The anemia of chronic diseaseSeminars in Hematology1983204
40DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic SyndromesSeminars in Hematology2008203
41Treatment of Adult Acute Lymphoblastic LeukemiaSeminars in Hematology2009199
42Pathobiology of Secondary Immune ThrombocytopeniaSeminars in Hematology2009197
43Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adultsSeminars in Hematology1998196
44Preclinical safety of a nucleic acid[ndash ]targeted Helinx[trade ] compound: A clinical perspectiveSeminars in Hematology2001192
45CD20 as a Target for Therapeutic Type I and II Monoclonal AntibodiesSeminars in Hematology2010190
46Mechanisms of drug resistance in hematologic malignanciesSeminars in Hematology1997190
47The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990Seminars in Hematology1990187
48Pharmacology of 5-Aza-2′-deoxycytidine (decitabine)Seminars in Hematology2005185
49Molecular genetics of human leukemias: New insights into therapySeminars in Hematology2002183
50Autoantibodies and autoantigens in chronic immune thrombocytopenic purpuraSeminars in Hematology2000179